UB Paderborn / Katalog / Suche / in CDI

Binding properties of a selective tritiated vasopressin V2 receptor antagonist, [3H]-SR 121463

Kidney international, 2000-10, Vol.58 (4), p.1613-1622

2000

Volltextzugriff (PDF)

Comparative pharmacology of bovine, human and rat vasopressin receptor isoforms

European journal of pharmacology, 2004-10, Vol.501 (1), p.59-69

2004

Volltextzugriff (PDF)

Receptor for advanced glycation endproducts controls deleterious lung inflammation in severe Pseudomonas aeruginosa pneumonia in immunosuppressed mice

Critical care (London, England), 2012-01, Vol.16 (S3), p.P14-P14, Article P14

2012

Volltextzugriff (PDF)

Importance of the phenotypic state of vascular smooth muscle cells on the binding and the mitogenic activity of endothelin

Peptides (New York, N.Y. : 1980), 1991-05, Vol.12 (3), p.575-579

1991

Volltextzugriff (PDF)

Selective blockade of vasopressin V2 receptors reveals significant V2‐mediated water reabsorption in Brattleboro rats with diabetes insipidus

Nephrology, dialysis, transplantation, 2001-04, Vol.16 (4), p.725-734

2001

Volltextzugriff (PDF)

Effect of SR-49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells

American journal of physiology. Heart and circulatory physiology, 1995-01, Vol.268 (1), p.H404-H410

1995

Volltextzugriff (PDF)

Vasopressin receptors in human adrenal medulla and pheochromocytoma

The journal of clinical endocrinology and metabolism, 1999-06, Vol.84 (6), p.2195-2203

1999

Volltextzugriff (PDF)

Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women

BJOG : an international journal of obstetrics and gynaecology, 1999-10, Vol.106 (10), p.1047-1053

1999

Volltextzugriff (PDF)

Binding properties of three neuropeptide Y receptor subtypes from zebrafish: comparison with mammalian Y1 receptors

Biochemical pharmacology, 2000-12, Vol.60 (12), p.1815-1822

2000

Volltextzugriff (PDF)

The cloned guinea pig neuropeptide Y receptor Y1 conforms to other mammalian Y1 receptors

Peptides (New York, N.Y. : 1980), 1999, Vol.20 (9), p.1043-1053

1999

Volltextzugriff (PDF)

Effect of SR-49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells

American journal of physiology. Heart and circulatory physiology, 1995, Vol.37 (1), p.H404-H410

1995

Volltextzugriff (PDF)

The cloned guinea pig neuropeptide Y receptor Y 1 conforms to other mammalian Y 1 receptors

Peptides (New York, N.Y. : 1980), 1999-09, Vol.20 (9), p.1043-1053

1999

Volltextzugriff (PDF)

Aquaretic and hormonal effects of a vasopressin V 2 receptor antagonist after acute and long-term treatment in rats

European journal of pharmacology, 2000-04, Vol.394 (1), p.131-138

2000

Volltextzugriff (PDF)

Acute renal response to the non-peptide vasopressin V 2 -receptor antagonist SR 121463B in anesthetized rats

Naunyn-Schmiedeberg's archives of pharmacology, 2000-09, Vol.362 (3), p.201-207

2000

Volltextzugriff (PDF)

The Discovery of Novel Vasopressin V(1b) Receptor Ligands for Pharmacological, Functional and Structural Investigations

Journal of neuroendocrinology, 2004-04, Vol.16 (4), p.356

2004

Volltextzugriff (PDF)

Effect of SR121463, a selective non-peptide vasopressin V2 receptor antagonist, in a rabbit model of ocular hypertension

Journal of ocular pharmacology and therapeutics, 2000-06, Vol.16 (3), p.203

2000

Volltextzugriff (PDF)

Effect of SR121463, a Selective Non-Peptide Vasopressin V 2 Receptor Antagonist, in a Rabbit Model of Ocular Hypertension

Journal of ocular pharmacology and therapeutics, 2000-06, Vol.16 (3), p.203-216

2000

Volltextzugriff (PDF)

Binding of the Non-Peptide Vasopressin V1a Receptor Antagonist SR-49059 in the Rat Brain: An in vitro and in vivo Autoradiographic Study

Neuroendocrinology, 1999-02, Vol.69 (2), p.113-120

1999

Volltextzugriff (PDF)

Khusimol, a Non-Peptide Ligand for Vasopressin V1a Receptors

Journal of natural products (Washington, D.C.), 1994-10, Vol.57 (10), p.1329-1335

1994

Volltextzugriff (PDF)

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V sub(1b) receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders

Proceedings of the National Academy of Sciences - PNAS, 2002-04, Vol.99 (9), p.6370-6375

2002

Volltextzugriff (PDF)

The Discovery of Novel Vasopressin V 1b Receptor Ligands for Pharmacological, Functional and Structural Investigations

Journal of neuroendocrinology, 2004-04, Vol.16 (4), p.356-361

2004

Volltextzugriff (PDF)

Autoradiographic localization of vasopressin V1a receptors in the rat kidney using [3H]-SR 49059

Kidney international, 1996-08, Vol.50 (2), p.499-505

1996

Volltextzugriff (PDF)

Effects of the vasopressin V1a receptor antagonist, SR 49059, on the response of human uterine arteries to vasopressin and other vasoactive substances

Acta obstetricia et gynecologica Scandinavica, 1998, Vol.77 (1), p.3-7

1998

Volltextzugriff (PDF)

Pharmacological profile of SR 49059, a new potent and specific vasopressin V1a receptor antagonist

Neuropeptides (Edinburgh), 1994-04, Vol.26, p.33

Serradeil-Le Gal, C.

1994

Volltextzugriff (PDF)

Pharmacological profile of SR 49059, a new potent and specific vasopressin V 1a receptor antagonist

Neuropeptides (Edinburgh), 1994, Vol.26, p.33-33

Serradeil-Le Gal, C.

1994

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Binding properties of a selective tritiated vasopressin V2 receptor antagonist, [3H]-SR 121463

Comparative pharmacology of bovine, human and rat vasopressin receptor isoforms

Receptor for advanced glycation endproducts controls deleterious lung inflammation in severe Pseudomonas aeruginosa pneumonia in immunosuppressed mice

Importance of the phenotypic state of vascular smooth muscle cells on the binding and the mitogenic activity of endothelin

Selective blockade of vasopressin V2 receptors reveals significant V2‐mediated water reabsorption in Brattleboro rats with diabetes insipidus

Effect of SR-49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells

Vasopressin receptors in human adrenal medulla and pheochromocytoma

Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women

Binding properties of three neuropeptide Y receptor subtypes from zebrafish: comparison with mammalian Y1 receptors

The cloned guinea pig neuropeptide Y receptor Y1 conforms to other mammalian Y1 receptors

Effect of SR-49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells

The cloned guinea pig neuropeptide Y receptor Y 1 conforms to other mammalian Y 1 receptors

Aquaretic and hormonal effects of a vasopressin V 2 receptor antagonist after acute and long-term treatment in rats

Acute renal response to the non-peptide vasopressin V 2 -receptor antagonist SR 121463B in anesthetized rats

The Discovery of Novel Vasopressin V(1b) Receptor Ligands for Pharmacological, Functional and Structural Investigations

Effect of SR121463, a selective non-peptide vasopressin V2 receptor antagonist, in a rabbit model of ocular hypertension

Effect of SR121463, a Selective Non-Peptide Vasopressin V 2 Receptor Antagonist, in a Rabbit Model of Ocular Hypertension

Binding of the Non-Peptide Vasopressin V1a Receptor Antagonist SR-49059 in the Rat Brain: An in vitro and in vivo Autoradiographic Study

Khusimol, a Non-Peptide Ligand for Vasopressin V1a Receptors

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V sub(1b) receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders

The Discovery of Novel Vasopressin V 1b Receptor Ligands for Pharmacological, Functional and Structural Investigations

Autoradiographic localization of vasopressin V1a receptors in the rat kidney using [3H]-SR 49059

Effects of the vasopressin V1a receptor antagonist, SR 49059, on the response of human uterine arteries to vasopressin and other vasoactive substances

Pharmacological profile of SR 49059, a new potent and specific vasopressin V1a receptor antagonist

Pharmacological profile of SR 49059, a new potent and specific vasopressin V 1a receptor antagonist

Suchergebnisse filtern